| Market Cap | ₹10,387Cr |
| ROE | 10.89% |
| P/E Ratio(TTM) | 68.04 |
| EPS(TTM) | 29.46 |
| P/B Ratio | 7.85 |
| Dividend Yield | 0.00% |
| Industry P/E | 67.33 |
| Book Value | 255.31 |
| Debt to Equity | 0.15 |
| Face Value | 2 |
| Parent Organisation | Metropolis Healthcare Limited |
| Managing Director | Ms. Ameera Shah |
| NSE Symbol | METROPOLIS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 50.47 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 69.36 | ||
| Thyrocare Technologies | NA (0.00%) | 57.90 | ||
| Krsnaa Diagnostics | NA (0.00%) | 31.88 |